Belfast, United Kingdom

Hugh Morgan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fusion Antibodies Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hugh Morgan. Retrieved from https://idiyas.com/inventor/hugh-morgan-tap2m988

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hugh Morgan - Innovator in Antibody Technology

Introduction

Hugh Morgan is a notable inventor based in Belfast Antrim, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries. His innovative work has the potential to enhance the efficiency of antibody binding and affinity maturation.

Latest Patents

Hugh Morgan holds a patent for an "Antibody library and method." This patent relates to methods of generating antibody libraries, which are crucial for improving antibody binding through affinity maturation assays. The invention involves identifying specific motifs in the nucleotide sequence of target antibodies that can be recognized by deamination somatic hypermutation enzymes. By creating a small library of variants incorporating these mutations, a higher proportion of variants with increased affinity can be produced. The technique has been demonstrated on trastuzumab and Cathepsin S antibodies, showcasing its effectiveness.

Career Highlights

Hugh Morgan is associated with Fusion Antibodies Limited, where he applies his expertise in antibody technology. His work has contributed to advancements in the field, particularly in the generation of antibody libraries that can significantly improve therapeutic outcomes.

Collaborations

Hugh Morgan has collaborated with notable colleagues, including Richard John Buick and Christopher Scott. These collaborations have further enriched his research and development efforts in antibody technology.

Conclusion

Hugh Morgan's innovative work in antibody libraries represents a significant advancement in biotechnology. His contributions have the potential to transform the landscape of antibody development and improve therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…